| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.85B | $1.87B | $1.84B |
| YoY Revenue Growth % | -1.2% | +1.6% | — |
| Gross Profit | $744.8M | $829.5M | — |
| Gross Margin % | 40.4% | 44.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $663.9M | $686.3M | $647.1M |
| Operating Margin % | 36.0% | 36.8% | 35.2% |
| Net Income (GAAP) | $304.1M | $309.6M | $266.6M |
| EBITDA (Normalized) | $776.4M | $804.1M | $713.3M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $454.3M | $481.4M | $907.9M |
| Capital Expenditures (CapEx) | $140.6M | $147.3M | $82.7M |
| Free Cash Flow (FCF) | $313.7M | $334.1M | $825.2M |
| FCF Margin % | 17.0% | 17.9% | 44.9% |
| Return on Invested Capital (ROIC %) | 13.6% | 13.6% | 24.6% |
| Cash & Short-Term Equivalents | $905.8M | $595.8M | — |
| Total Debt (Short + Long Term) | $3.53B | $3.08B | $804.8M |
| Total Stockholders' Equity | $1.23B | $1.49B | $1.65B |